17:23

CALQUENCE® (acalabrutinib) Pooled Safety Analysis – Dr Pinilla-lbarz, MD

20:01

CALQUENCE® (acalabrutinib) MAIC of ASCEND and ALPINE – Dr Skarbnik, MD

1:08:05

A Patient Story

18:35

CALQUENCE® (acalabrutinib) ACE-CL-001 (ibrutinib-intolerant cohort) – Dr Raval, MD

15:59

CALQUENCE® (acalabrutinib) Long-Term Data – Dr Brem, MD

15:22

CALQUENCE® (acalabrutinib) ELEVATE-TN data, incl. High-Risk Subgroups – Dr Abutalib, MD

16:42

CALQUENCE® (acalabrutinib) Patient Management & Adherence – Bradley, NP

14:09

CALQUENCE® (acalabrutinib) Safety Data – Dr Levy, MD